Merck sold $952 million of its Covid-19 treatment pill molnupiravir in the fourth quarter, saying Thursday it’s on track to sell another $5 billion to $6 billion more this year.
Most of its sales so… [+2950 chars]
Merck expects to sell $5 billion to $6 billion of its new Covid treatment pill in 2022 – CNBC